You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Adrenocortical Carcinoma

Showing 1 - 25 of 7,763
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Adverse Event of Mitotane Therapy in Adrenocortical

Not yet recruiting
  • Adrenocortical Carcinoma
    • (no location specified)
    Apr 21, 2023

    Adrenocortical Carcinoma Trial in Ann Arbor (68Ga-R8760 injection at pre-defined dose levels, 68GA-R8760 injection)

    Recruiting
    • Adrenocortical Carcinoma
    • 68Ga-R8760 injection at pre-defined dose levels
    • 68GA-R8760 injection
    • Ann Arbor, Michigan
      University of Michigan Nuclear Medicine
    Aug 11, 2023

    Adrenal Vein Sampling asTool to Identify Biomarkers That Aid

    Recruiting
    • Adrenocortical Carcinoma
    • Blood sampling.
    • Rotterdam, Netherlands
      Erasmus MC
    Dec 14, 2022

    Adrenocortical Carcinoma, ACC, Metastatic Adrenocortical Carcinoma Trial in United States (Ablative Radiotherapy, Pembrolizumab)

    Recruiting
    • Adrenocortical Carcinoma
    • +2 more
    • Basking Ridge, New Jersey
    • +6 more
    Sep 27, 2023

    Adrenocortical Carcinoma Trial in Brescia (Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG,

    Recruiting
    • Adrenocortical Carcinoma
    • Etoposide, doxorubicin, cisplatin and Mitotane plus Megestrol Acetate 160 MG
    • Etoposide, doxorubicin, cisplatin and Mitotane plus Placebo
    • Brescia, Italy
      Alfredo Berruti
    Jun 12, 2023

    Adrenocortical Carcinoma Trial (Pembrolizumab 25 MG/ML [Keytruda])

    Not yet recruiting
    • Adrenocortical Carcinoma
    • Pembrolizumab 25 MG/ML [Keytruda]
    • (no location specified)
    Sep 29, 2022

    Neuroendocrine Neoplasms Including Adrenocortical Carcinoma

    Recruiting
    • Neuroendocrine Tumors
    • Carcinoma, Neuroendocrine
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 20, 2023

      Adrenocortical Carcinoma Trial (Camrelizumab)

      Recruiting
      • Adrenocortical Carcinoma
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      Dec 16, 2022

      Adrenocortical Carcinoma Trial in Houston (Mitotane, Pembrolizumab)

      Not yet recruiting
      • Adrenocortical Carcinoma
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 22, 2022

      Children and Adults With Adrenocortical Cancer (ACC)

      Terminated
      • Adrenocortical Carcinoma
      • Adrenocortical Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 13, 2023

        Metastatic Carcinoma in the Adrenal Cortex, Stage III Adrenal Cortex Carcinoma AJCC v8, Stage IV Adrenal Cortex Carcinoma AJCC

        Active, not recruiting
        • Metastatic Carcinoma in the Adrenal Cortex
        • +3 more
        • Houston, Texas
          M D Anderson Cancer Center
        Dec 12, 2022

        Survival Analysis in Children and Adults Adrenocortical Cancer

        Active, not recruiting
        • Adrenocortical Carcinoma
          • Bethesda, Maryland
            National Cancer Institute (NCI)
          Jan 20, 2023

          Lymph Node Dissection in Surgical Management of Adrenal Cortical

          Recruiting
          • Adrenocortical Carcinoma
          • Adrenalectomy with or without lymphadenectomy
          • Rome, Italy
            Fondazione Policlinico Universitario Agostino Gemelli IRCCS
          Feb 28, 2023

          Adrenal Diseases- Laparoscopic vs. Robotic-assisted

          Recruiting
          • Adrenal Tumor
          • +12 more
            • Olomouc, Czechia
              University hospital Olomouc
            Sep 17, 2023

            Adrenocortical Carcinoma, Peritoneal Carcinomatosis Trial in New York (Cisplatin, Sodium thiosulfate, Cytoreductive surgery)

            Recruiting
            • Adrenocortical Carcinoma
            • Peritoneal Carcinomatosis
            • New York, New York
              Columbia University Medical Center
            Mar 17, 2022

            Adrenocortical Carcinoma Trial in United States (Relacorilant, Pembrolizumab)

            Recruiting
            • Adrenocortical Carcinoma
            • Stanford, California
            • +5 more
            Jun 27, 2022

            Serum Free Proteins in Patients With Adrenocortical Carcinoma

            Active, not recruiting
            • Adrenocortical Carcinoma
            • London, United Kingdom
              King's College Hospital NHS Foundation Trust
            Apr 19, 2022

            Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)

            Not yet recruiting
            • Neuroendocrine Carcinomas
            • +4 more
            • Bethesda, Maryland
              National Institutes of Health Clinical Center
            Sep 22, 2023

            Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

            Recruiting
            • Genitourinary Cancer
            • +7 more
            • La Jolla, California
            • +5 more
            Jul 5, 2022

            Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma Trial in Worldwide (EO2401)

            Recruiting
            • Adrenocortical Carcinoma
            • +2 more
            • EO2401
            • Houston, Texas
            • +9 more
            Dec 7, 2021

            Locally Advanced Adrenal Cortical Carcinoma, Metastatic Adrenal Cortical Carcinoma, Stage III Adrenal Cortical Carcinoma AJCC v8

            Not yet recruiting
            • Locally Advanced Adrenal Cortical Carcinoma
            • +4 more
            • Atezolizumab
            • +5 more
            • Atlanta, Georgia
            • +1 more
            Aug 17, 2023

            Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

            Not yet recruiting
            • Adrenal Cortical Carcinoma
            • +3 more
            • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
            • Shanghai, Shanghai, China
              Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
            Nov 19, 2023

            ENSAT Stage I Adrenal Cortex Carcinoma, ENSAT Stage II Adrenal Cortex Carcinoma, ENSAT Stage III Adrenal Cortex Carcinoma Trial

            Recruiting
            • ENSAT Stage I Adrenal Cortex Carcinoma
            • +2 more
            • Ann Arbor, Michigan
            • +3 more
            Dec 13, 2022

            Adrenocortical Carcinoma Trial (Pembrolizumab / Lenvatinib)

            Not yet recruiting
            • Adrenocortical Carcinoma
            • Pembrolizumab / Lenvatinib
            • (no location specified)
            Nov 15, 2021

            German Adrenocortical Carcinoma Registry

            Recruiting
            • Adrenocortical Carcinoma
              • Wuerzburg, Germany
                University of Wuerzburg
              Jun 1, 2021